BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7207707)

  • 1. Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant.
    Holmgren G; Brundin A; Gustavson KH; Sjögren S; Kleijer WJ; Niermeijer MF
    Neuropediatrics; 1980 Nov; 11(4):377-83. PubMed ID: 7207707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intermittent maple syrup urine disease in a 12-year-old boy: clinical aspects, diagnosis and treatment].
    Fritsch G; Langenbeck U; Wendel U; Lehnert W; Palm W; Steger W
    Klin Padiatr; 1983; 195(5):351-4. PubMed ID: 6632715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant maple syrup urine disease in mother and daughter.
    Zaleski LA; Dancis J; Cox RP; Hutzler J; Zaleski WA; Hill A
    Can Med Assoc J; 1973 Aug; 109(4):299-300 passim. PubMed ID: 4730202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of maple syrup urine disease in Canada. Committee for improvement of Hereditary Disease Management.
    Can Med Assoc J; 1976 Nov; 115(10):1005-13. PubMed ID: 1032577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmoplegia and bulbar palsy in variant form of maple syrup urine disease.
    Chhabria S; Tomasi LG; Wong PW
    Ann Neurol; 1979 Jul; 6(1):71-2. PubMed ID: 507761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild variant of maple syrup urine disease.
    Kovács J; Kiss P
    Acta Paediatr Acad Sci Hung; 1978; 19(2):137-43. PubMed ID: 707084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intermittent neurological symptoms in a girl with a MSUD-variant].
    Brundin A; Gustavson KH; Holmgren G; Sjögren S
    Lakartidningen; 1979 Mar; 76(12):1095-6. PubMed ID: 431205
    [No Abstract]   [Full Text] [Related]  

  • 10. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The intermediate form of maple syrup disease].
    Rittinger O; Bachmann C; Irnberger T; Pilz P; Walter GF; Wendel U; Plöchl E
    Klin Padiatr; 1986; 198(1):37-43. PubMed ID: 3959487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maple syrup urine disease: case report of 2 Thai infants.
    Chiemchanya S; Suthutvoravut U; Visudhiphan P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():116-20. PubMed ID: 2732631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
    Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
    Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heterogeneity of leucinosis. Correlations between clinical manifestations, protein tolerance and enzyme deficiency].
    Saudubray JM; Amédée-Manesme O; Munnich A; Ogier H; Depondt E; Charpentier C; Coudé FX; Rey F; Frézal J
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():735-40. PubMed ID: 6897702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
    Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y
    Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and alanine metabolism in children with maple syrup urine disease.
    Haymond MW; Ben-Galim E; Strobel KE
    J Clin Invest; 1978 Aug; 62(2):398-405. PubMed ID: 670400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.